68 related articles for article (PubMed ID: 28097409)
21. Optimal detection of clinically relevant mutations in colorectal carcinoma: sample pooling overcomes intra-tumoral heterogeneity.
Nelson AC; Boone J; Cartwright D; Thyagarajan B; Kincaid R; Lambert AP; Karnuth K; Henzler C; Yohe S
Mod Pathol; 2018 Feb; 31(2):343-349. PubMed ID: 29027537
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.
Bae JM; Kim JH; Kang GH
Histol Histopathol; 2013 May; 28(5):585-95. PubMed ID: 23341177
[TBL] [Abstract][Full Text] [Related]
23. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.
Murcia O; Juárez M; Hernández-Illán E; Egoavil C; Giner-Calabuig M; Rodríguez-Soler M; Jover R
World J Gastroenterol; 2016 Apr; 22(13):3516-30. PubMed ID: 27053844
[TBL] [Abstract][Full Text] [Related]
24. Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer.
Jones HG; Jenkins G; Williams N; Griffiths P; Chambers P; Beynon J; Harris D
World J Surg; 2017 May; 41(5):1375-1383. PubMed ID: 28097409
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.
Bae JM; Kim JH; Cho NY; Kim TY; Kang GH
Br J Cancer; 2013 Aug; 109(4):1004-12. PubMed ID: 23900220
[TBL] [Abstract][Full Text] [Related]
27. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
[TBL] [Abstract][Full Text] [Related]
28. Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer.
Liu J; Tang L; Yi J; Li G; Lu Y; Xu Y; Zhao S; Mao R; Li X; Ren L; Wang K
BMC Gastroenterol; 2019 Nov; 19(1):173. PubMed ID: 31690257
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
[TBL] [Abstract][Full Text] [Related]
30. Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity.
Smallwood SA; Lee HJ; Angermueller C; Krueger F; Saadeh H; Peat J; Andrews SR; Stegle O; Reik W; Kelsey G
Nat Methods; 2014 Aug; 11(8):817-820. PubMed ID: 25042786
[TBL] [Abstract][Full Text] [Related]
31. Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications.
Kosmidou V; Oikonomou E; Vlassi M; Avlonitis S; Katseli A; Tsipras I; Mourtzoukou D; Kontogeorgos G; Zografos G; Pintzas A
Hum Mutat; 2014 Mar; 35(3):329-40. PubMed ID: 24352906
[TBL] [Abstract][Full Text] [Related]
32. The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer.
Fadhil W; Ibrahem S; Seth R; AbuAli G; Ragunath K; Kaye P; Ilyas M
Histopathology; 2012 Dec; 61(6):1117-24. PubMed ID: 22882224
[TBL] [Abstract][Full Text] [Related]
33. Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk A; Almendro V; Polyak K
Nat Rev Cancer; 2012 Apr; 12(5):323-34. PubMed ID: 22513401
[TBL] [Abstract][Full Text] [Related]
34. Genetic heterogeneity and cancer drug resistance.
Turner NC; Reis-Filho JS
Lancet Oncol; 2012 Apr; 13(4):e178-85. PubMed ID: 22469128
[TBL] [Abstract][Full Text] [Related]
35. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Gerlinger M; Rowan AJ; Horswell S; Math M; Larkin J; Endesfelder D; Gronroos E; Martinez P; Matthews N; Stewart A; Tarpey P; Varela I; Phillimore B; Begum S; McDonald NQ; Butler A; Jones D; Raine K; Latimer C; Santos CR; Nohadani M; Eklund AC; Spencer-Dene B; Clark G; Pickering L; Stamp G; Gore M; Szallasi Z; Downward J; Futreal PA; Swanton C
N Engl J Med; 2012 Mar; 366(10):883-892. PubMed ID: 22397650
[TBL] [Abstract][Full Text] [Related]
36. Molecular morphometric analysis shows relative intra-tumoural homogeneity for KRAS mutations in colorectal cancer.
Farber L; Efrati E; Elkin H; Peerless Y; Sabo E; Ben-Izhak O; Hershkovitz D
Virchows Arch; 2011 Nov; 459(5):487-93. PubMed ID: 22016105
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]